NASDAQ:ABUS   Arbutus Biopharma Corporation
Fib level as of what i see now at .786 looks to be right here. its also where prior resistance may turn into support for the price. also the 200 sma has had time to catch up to the price of the stock and can be another indicator for the patient people on the sidelines that the chart has leveled off for now.
Pernyataan Penyangkalan

Informasi dan publikasi tidak dimaksudkan untuk menjadi, dan bukan merupakan saran keuangan, investasi, perdagangan, atau rekomendasi lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Persyaratan Penggunaan.